KALMAR INVESTMENTS INC /DE/ - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
KALMAR INVESTMENTS INC /DE/ ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$25,629,000
-35.9%
148,310
-57.4%
0.48%
-35.8%
Q4 2014$39,981,000
-26.2%
347,845
+0.4%
0.74%
-28.0%
Q3 2014$54,145,000
-9.7%
346,550
-28.7%
1.03%
-0.1%
Q2 2014$59,989,000
+20.9%
486,335
+1.5%
1.03%
+23.2%
Q1 2014$49,633,000
+15.1%
479,040
-0.0%
0.84%
+16.2%
Q4 2013$43,104,000
+36.1%
479,250
+1.2%
0.72%
+28.6%
Q3 2013$31,682,000
+0.8%
473,720
-0.3%
0.56%
-9.4%
Q2 2013$31,438,000475,2500.62%
Other shareholders

There were no reported owners of SALIX PHARMACEUTICALS INC in Q2 2013.

NameSharesValueWeighting ↓
View complete list of SALIX PHARMACEUTICALS INC shareholders